The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Evotec and Jain Foundation Expand Research Collaboration (2014-09-15)
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and the Jain Foundation Inc. today announced that they have further extended and expanded the collaboration first signed in 2012 and extended last year. This next phase of collaboration includ...
- Affimed Prices US IPO of $56m, with $8.4m Greenshoe (2014-09-12)
Affimed Therapeutics today announced the pricing of its initial public offering of 8,000,000 common shares at an initial public offering price of $7.00 per common share. In addition, Affimed has granted the underwriters a 30-day option to purchase up to an addition...
- Merck Serono Discontinues Tecemotide in Phase 3 NSCLC Study (2014-09-12)
Merck announced today that its biopharmaceutical division Merck Serono will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) as a monotherapy in Stage III non-small cel...
- Mologen Starts Phase 3 with MGN1703 in Colorectal Cancer (2014-09-11)
> First patient enrolled > Pivotal study to evaluate overall survival MOLOGEN AG has enrolled the first patient in the international IMPALA study. Primary objective of the phase III pivotal trial is to prove that a switch maintenance therapy with the cancer...
- ProBioGen to Invest €20m in Manufacturing Expansion (2014-09-09)
On the occasion of its 20th anniversary, ProBioGen AG announced to invest 20€ million and to double its workforce. CEO Dr. Wieland Wolf welcomed scientific, business and political guests in a ceremony in Berlin on September 4, 2014. On behalf of pharmaceutical a...
- Angle plc Announces Collaboration with UKE (2014-09-08)
ANGLE plc (AIM: AGL), the specialist medtech company, is pleased to announce it has signed a collaboration agreement with The University Medical Center Hamburg-Eppendorf (UKE), a world leader in circulating tumour cell (CTC) research and part of the University Canc...
- Hyperion Terminates DiaPep277, Misconduct of Andromeda (2014-09-08)
Company to Host Conference Call Today at 9:00 a.m. ET (6:00 a.m. PT) Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced it is terminating development of DiaPep277 for newly diagnosed Type 1 diabetes. The company has uncovered evidence that certain emplo...
- Evotec Announces that Hyperion Terminates DiaPep277 Program (2014-09-08)
Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) was informed that US company Hyperion Therapeutics, Inc. ("Hyperion") is terminating the development of DiaPep277(R) for newly diagnosed Type 1 diabetes. In a press release p...
- Bellevue Group Acquires Adamant Biomedical Investments AG (2014-09-05)
o Acquisition of investment funds and mandates with assets under management of CHF 831 million, bringing total assets under management at Bellevue Asset Management to CHF 3.9 billion o Integration of Adamant enhances Bellevue Asset Management's investment expert...
- Arthur Levinson Resigns from Roche’s Board of Directors (2014-09-04)
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Arthur D. Levinson has resigned from the Board of Directors, effective immediately. Arthur D. Levinson made this decision so as to avoid any conflict of interest given his role as Chief Executive Officer at Ca...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)